首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: Relating plasma circulation lifetimes to protein binding
Authors:Nancy Dos Santos  Christine Allen  Malathi Anantha  Ryan C Gallagher  Katarina Edwards  Lacey Samuels  Marcel B Bally
Institution:a Department of Advanced Therapeutics, British Columbia Cancer Agency, 675 West 10th Avenue, Vancouver, BC, Canada V5Z 1L3
b Department of Pathology and Laboratory Medicine, University of British Columbia, 2211 Wesbrook Mall, Vancouver, BC, Canada V6T 2B5
c Leslie Dan Faculty of Pharmacy, University of Toronto, 19 Russell Street, Toronto, ON, Canada M5S 2S2
d Department of Physical Chemistry, Uppsala University, Box 579, S-751 23 Uppsala, Sweden
e Botany Department, University of British Columbia, 6270 University Blvd, Vancouver, BC, Canada V6T 1Z4
f Faculty of Pharmaceutical Sciences, University of British Columbia, 2146 East Mall, Vancouver, BC, Canada V6T 1Z3
Abstract:The incorporation of poly(ethylene glycol) (PEG)-conjugated lipids in lipid-based carriers substantially prolongs the circulation lifetime of liposomes. However, the mechanism(s) by which PEG-lipids achieve this have not been fully elucidated. It is believed that PEG-lipids mediate steric stabilization, ultimately reducing surface-surface interactions including the aggregation of liposomes and/or adsorption of plasma proteins. The purpose of the studies described here was to compare the effects of PEG-lipid incorporation in liposomes on protein binding, liposome-liposome aggregation and pharmacokinetics in mice. Cholesterol-free liposomes were chosen because of their increasing importance as liposomal delivery systems and their marked sensitivity to protein binding and aggregation. Specifically, liposomes containing various molecular weight PEG-lipids at a variety of molar proportions were analyzed for in vivo clearance, aggregation state (size exclusion chromatography, quasi-elastic light scattering, cryo-transmission and freeze fracture electron microscopy) as well as in vitro and in vivo protein binding. The results indicated that as little as 0.5 mol% of 1,2-distearoyl-sn-glycero-3-phosphatidylethanolamine (DSPE) modified with PEG having a mean molecular weight of 2000 (DSPE-PEG2000) substantially increased plasma circulation longevity of liposomes prepared of 1,2-distearoyl-sn-glycero-3-phosphatidylcholine (DSPC). Optimal plasma circulation lifetimes could be achieved with 2 mol% DSPE-PEG2000. At this proportion of DSPE-PEG2000, the aggregation of DSPC-based liposomes was completely precluded. However, the total protein adsorption and the protein profile was not influenced by the level of DSPE-PEG2000 in the membrane. These studies suggest that PEG-lipids reduce the in vivo clearance of cholesterol-free liposomal formulations primarily by inhibition of surface interactions, particularly liposome-liposome aggregation.
Keywords:ANOVA  analysis of variance  AUC  area-under-the-curve  BCA  bicinchoninic acid  CH  cholesterol  CHE  cholesteryl hexadecyl ether  DDP  didodecylphosphate  DOPE  1  2-dioleoyl-sn-glycero-3-phosphatidylethanolamine  DSPC  1  2-distearoyl-sn-glycero-3-phosphatidylcholine  DSPE  1  2-distearoyl-sn-glycero-3-phosphatidylethanol-amine  3[H]  tritium radiolabel  HEPES  N-[2-hydroxyethyl]piperazine-N&prime  -[2-ethanesulfonic acid]  HBS  HEPES buffered saline  pH 7  4  LUV  large unilamellar vesicle  MPS  mononuclear phagocytic system  PAGE  polyacrylamide gel electrophoresis  PB  protein binding (μmol protein/μmol lipid)  PC  phosphatidylcholine  PE  phosphatidylethanolamine  PEG  poly(ethylene glycol)  PK  pharmacokinetic  QELS  quasielastic light scattering  SDS  sodium dodecyl sulphate  Tc  phase transition temperature
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号